ASX:EVEFood, Beverage & TobaccoPackaged Foods & Meats
EVE HEALTH GROUP ORD
$0.025
+$0.001 (+4.17%)
Day Range
$0.024 - $0.025
52 Week Range
$0.017 - $0.044
Volume
50.00K
Avg Volume (10D)
347.11K
Market Cap
$8.81M
Price Chart
Market Statistics
Open$0.024
Previous Close$0.024
Day High$0.025
Day Low$0.024
52 Week High$0.044
52 Week Low$0.017
Valuation
Market Cap8.81M
Shares Outstanding352.33M
Price to Book1.82
Trading Activity
Volume50.00K
Value Traded1.22K
Bid$0.023 × 25,000
Ask$0.026 × 417,900
Performance
1 Day0.00%
5 Day-14.29%
13 Week14.29%
52 Week-40.00%
YTD14.29%
Technical Indicators
RSI (14)42.40
50-Day SMA$0.025
200-Day SMA$0.026
Latest News
Biotechnology
EVE Health Appoints New CEO to Lead Company Through Next Phase of Growth
EVE Health appoints COO Ben Rohr as new CEO to drive next growth phase and accelerate commercialisation; Damian Wood shifts to regulatory/medical affairs.
1 min read
Biotechnology
EVE Health Increases Capital Raising to $1.3m with $400,000 Cornerstone Investment
EVE Health Group lifts capital raise to $1.3m with $400k cornerstone, signalling reformulated-drug strategy and new science adviser amid Libbo launch.
1 min read
Biotechnology
EVE Health Group Raises $0.9m to Advance Reformulated Pharmaceutical Pipeline
EVE Health Group raises $0.904m via placement to push reformulated drug delivery pipeline, accelerating IP, regulatory work and licensing talks.
1 min read
Biotechnology
EVE Health Advances Reformulated Drugs Targeting Sexual Health and Cardiovascular Markets
EVE Health advances reformulated ED/PE sprays and Apixaban delivery, expanding its sexual health and cardiovascular pipeline.
2 min read